Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | RGD Reference | Notes | Source | Original Reference(s) | Plekha2 | Rat | (-)-demecolcine | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of PLEKHA2 mRNA | CTD | PMID:23649840 | Plekha2 | Rat | 1,2-dichloroethane | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PLEKHA2 mRNA | CTD | PMID:28960355 | Plekha2 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of PLEKHA2 mRNA | CTD | PMID:22206623 | Plekha2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Plekha2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of PLEKHA2 mRNA | CTD | PMID:17555576 | Plekha2 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of PLEKHA2 mRNA | CTD | PMID:17942748 | Plekha2 | Rat | 17beta-estradiol | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of PLEKHA2 mRNA | CTD | PMID:23019147 | Plekha2 | Rat | 17beta-estradiol | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Estradiol results in decreased expression of PLEKHA2 mRNA | CTD | PMID:39298647 | Plekha2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Plekha2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLEKHA2 mRNA | CTD | PMID:21570461 | Plekha2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLEKHA2 mRNA | CTD | PMID:33387578 | Plekha2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLEKHA2 mRNA | CTD | PMID:34747641 | Plekha2 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PLEKHA2 mRNA | CTD | PMID:30851411 | Plekha2 | Rat | 2-palmitoylglycerol | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of PLEKHA2 mRNA | CTD | PMID:37199045 | Plekha2 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLEKHA2 mRNA | CTD | PMID:20188158 | Plekha2 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PLEKHA2 mRNA | CTD | PMID:26251327 | Plekha2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of PLEKHA2 mRNA | CTD | PMID:27685785 | Plekha2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of PLEKHA2 mRNA | CTD | PMID:30951980 | Plekha2 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Decitabine affects the expression of PLEKHA2 mRNA | CTD | PMID:23300844 | Plekha2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased more ... | CTD | PMID:37992649 | Plekha2 | Rat | all-trans-retinoic acid | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of PLEKHA2 mRNA | CTD | PMID:33167477 | Plekha2 | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of PLEKHA2 mRNA | CTD | PMID:35163327 | Plekha2 | Rat | aristolochic acid A | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of PLEKHA2 mRNA | CTD | PMID:33212167 | Plekha2 | Rat | arsane | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA2 more ... | CTD | PMID:40504410 | Plekha2 | Rat | arsenic atom | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA2 more ... | CTD | PMID:40504410 | Plekha2 | Rat | belinostat | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | belinostat results in decreased expression of PLEKHA2 mRNA | CTD | PMID:27188386 | Plekha2 | Rat | benzo[a]pyrene | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of PLEKHA2 mRNA | CTD | PMID:20064835 | Plekha2 | Rat | benzo[a]pyrene | affects methylation | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of PLEKHA2 intron | CTD | PMID:30157460 | Plekha2 | Rat | benzo[a]pyrene | decreases methylation | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of PLEKHA2 5' UTR | CTD | PMID:27901495 | Plekha2 | Rat | benzo[a]pyrene | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PLEKHA2 mRNA | CTD | PMID:27195522 | Plekha2 | Rat | benzo[a]pyrene | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of PLEKHA2 protein | CTD | PMID:32717239 | Plekha2 | Rat | benzo[a]pyrene | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of PLEKHA2 mRNA | CTD | PMID:19770486 | Plekha2 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLEKHA2 mRNA | CTD | PMID:19150397 PMID:20018196 PMID:20382639 | Plekha2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PLEKHA2 mRNA | CTD | PMID:25181051 | Plekha2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PLEKHA2 mRNA | CTD | PMID:32145629 | Plekha2 | Rat | bisphenol A | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PLEKHA2 mRNA | CTD | PMID:30951980 | Plekha2 | Rat | bisphenol F | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of PLEKHA2 mRNA | CTD | PMID:30951980 | Plekha2 | Rat | butan-1-ol | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... | CTD | PMID:29432896 | Plekha2 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Plekha2 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of PLEKHA2 intron | CTD | PMID:28392331 | Plekha2 | Rat | cadmium atom | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHA2 more ... | CTD | PMID:35301059 | Plekha2 | Rat | cadmium dichloride | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHA2 more ... | CTD | PMID:35301059 | Plekha2 | Rat | caffeine | decreases phosphorylation | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of PLEKHA2 protein | CTD | PMID:35688186 | Plekha2 | Rat | calcitriol | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of PLEKHA2 mRNA | CTD | PMID:16002434 | Plekha2 | Rat | carbon nanotube | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of PLEKHA2 mRNA | CTD | PMID:25554681 | Plekha2 | Rat | choline | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Plekha2 | Rat | cisplatin | affects expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Cisplatin affects the expression of PLEKHA2 mRNA | CTD | PMID:23300844 | Plekha2 | Rat | copper(II) chloride | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of PLEKHA2 mRNA | CTD | PMID:38568856 | Plekha2 | Rat | cyclosporin A | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of PLEKHA2 mRNA | CTD | PMID:20106945 PMID:21632981 PMID:25562108 | Plekha2 | Rat | D-glucose | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased more ... | CTD | PMID:37992649 | Plekha2 | Rat | dioxygen | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of PLEKHA2 mRNA | CTD | PMID:26516004 | Plekha2 | Rat | dorsomorphin | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Plekha2 | Rat | doxorubicin | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of PLEKHA2 mRNA | CTD | PMID:29803840 | Plekha2 | Rat | entinostat | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | entinostat results in increased expression of PLEKHA2 mRNA | CTD | PMID:26272509 | Plekha2 | Rat | entinostat | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Plekha2 | Rat | ethanol | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Ethanol results in increased expression of PLEKHA2 mRNA | CTD | PMID:23378141 | Plekha2 | Rat | ethanol | affects expression | ISO | Plekha2 (Mus musculus) | 6480464 | Ethanol affects the expression of PLEKHA2 mRNA | CTD | PMID:30319688 | Plekha2 | Rat | ethanol | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... | CTD | PMID:23378141 PMID:29432896 | Plekha2 | Rat | fluoranthene | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PLEKHA2 mRNA | CTD | PMID:28329830 | Plekha2 | Rat | folic acid | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Plekha2 | Rat | folic acid | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in increased expression of PLEKHA2 mRNA | CTD | PMID:23378141 | Plekha2 | Rat | formaldehyde | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of PLEKHA2 mRNA | CTD | PMID:23649840 | Plekha2 | Rat | FR900359 | decreases phosphorylation | ISO | PLEKHA2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of PLEKHA2 protein | CTD | PMID:37730182 | Plekha2 | Rat | fructose | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased more ... | CTD | PMID:37992649 | Plekha2 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of PLEKHA2 mRNA | CTD | PMID:33387578 | Plekha2 | Rat | glucose | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased more ... | CTD | PMID:37992649 | Plekha2 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of PLEKHA2 gene | CTD | PMID:35440735 | Plekha2 | Rat | glyphosate | decreases expression | EXP | | 6480464 | Glyphosate results in decreased expression of PLEKHA2 mRNA | CTD | PMID:38314887 | Plekha2 | Rat | ivermectin | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of PLEKHA2 protein | CTD | PMID:32959892 | Plekha2 | Rat | L-methionine | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Plekha2 | Rat | Licochalcone B | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | licochalcone B results in decreased expression of PLEKHA2 mRNA | CTD | PMID:33647349 | Plekha2 | Rat | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of PLEKHA2 mRNA | CTD | PMID:35283115 | Plekha2 | Rat | lipopolysaccharide | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of PLEKHA2 mRNA | CTD | PMID:35811015 | Plekha2 | Rat | lipopolysaccharide | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of PLEKHA2 mRNA | CTD | PMID:39241906 | Plekha2 | Rat | lipopolysaccharide | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLEKHA2 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Plekha2 | Rat | melphalan | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Melphalan results in decreased expression of PLEKHA2 mRNA | CTD | PMID:22363485 | Plekha2 | Rat | mercury dibromide | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of PLEKHA2 mRNA | CTD | PMID:26272509 | Plekha2 | Rat | mercury dibromide | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Plekha2 | Rat | methyl methanesulfonate | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of PLEKHA2 mRNA | CTD | PMID:23649840 | Plekha2 | Rat | niclosamide | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of PLEKHA2 mRNA | CTD | PMID:36318118 | Plekha2 | Rat | nitrates | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PLEKHA2 more ... | CTD | PMID:35964746 | Plekha2 | Rat | okadaic acid | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of PLEKHA2 mRNA | CTD | PMID:38832940 | Plekha2 | Rat | panobinostat | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Plekha2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PLEKHA2 mRNA | CTD | PMID:33387578 | Plekha2 | Rat | phenylmercury acetate | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of PLEKHA2 mRNA | CTD | PMID:26272509 | Plekha2 | Rat | phenylmercury acetate | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Plekha2 | Rat | pirinixic acid | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of PLEKHA2 mRNA | CTD | PMID:17426115 | Plekha2 | Rat | potassium chromate | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of PLEKHA2 mRNA | CTD | PMID:22714537 | Plekha2 | Rat | potassium dichromate | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Potassium Dichromate results in decreased expression of PLEKHA2 protein | CTD | PMID:23718831 | Plekha2 | Rat | quercetin | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of PLEKHA2 mRNA | CTD | PMID:21632981 | Plekha2 | Rat | rac-lactic acid | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PLEKHA2 mRNA | CTD | PMID:30851411 | Plekha2 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLEKHA2 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Plekha2 | Rat | SB 431542 | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Plekha2 | Rat | sodium arsenite | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PLEKHA2 mRNA | CTD | PMID:38568856 | Plekha2 | Rat | sodium arsenite | multiple interactions | ISO | Plekha2 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA2 more ... | CTD | PMID:40504410 | Plekha2 | Rat | sodium fluoride | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of PLEKHA2 mRNA | CTD | PMID:27862939 | Plekha2 | Rat | sunitinib | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of PLEKHA2 mRNA | CTD | PMID:31533062 | Plekha2 | Rat | tamoxifen | affects expression | ISO | Plekha2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of PLEKHA2 mRNA | CTD | PMID:17555576 | Plekha2 | Rat | testosterone | increases expression | ISO | Plekha2 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of PLEKHA2 mRNA | CTD | PMID:33848595 | Plekha2 | Rat | tetrachloromethane | affects expression | ISO | Plekha2 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of PLEKHA2 mRNA | CTD | PMID:17484886 | Plekha2 | Rat | thimerosal | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of PLEKHA2 mRNA | CTD | PMID:27188386 | Plekha2 | Rat | thiram | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Thiram results in decreased expression of PLEKHA2 mRNA | CTD | PMID:38568856 | Plekha2 | Rat | titanium dioxide | decreases methylation | ISO | Plekha2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PLEKHA2 promoter | CTD | PMID:35295148 | Plekha2 | Rat | torcetrapib | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of PLEKHA2 mRNA | CTD | PMID:23228038 | Plekha2 | Rat | trichostatin A | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of PLEKHA2 mRNA | CTD | PMID:24935251 | Plekha2 | Rat | triptonide | decreases expression | ISO | Plekha2 (Mus musculus) | 6480464 | triptonide results in decreased expression of PLEKHA2 mRNA | CTD | PMID:33045310 | Plekha2 | Rat | urethane | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of PLEKHA2 mRNA | CTD | PMID:28818685 | Plekha2 | Rat | valproic acid | increases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PLEKHA2 mRNA | CTD | PMID:23179753 PMID:24383497 PMID:24935251 PMID:26272509 | Plekha2 | Rat | valproic acid | multiple interactions | ISO | PLEKHA2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Plekha2 | Rat | vincristine | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of PLEKHA2 mRNA | CTD | PMID:23649840 | Plekha2 | Rat | vorinostat | decreases expression | ISO | PLEKHA2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of PLEKHA2 mRNA | CTD | PMID:27188386 | |






















